Arkolith/Insider Trading/CARA/Form 4

Vogelbaum Martin

DirectorCara Therapeutics, Inc. (CARA) · full profile →Form 4 · filed Sep 16, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$111K
Net Open-Market Flow
-$111K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 14, 2022Sell(S)11K$10.28$111K45K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-050320) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML